Begin main content

Intravenous Ketamine for the Treatment of Pain Syndromes: Clinical Effectiveness

Dernière mise à jour : 7 juin 2013
Numéro de projet : RB0591-000
Gamme de produits : Rapports d’examen rapide
Type de recherche : Appareils et systèmes
Type de rapport : Synthèse de résumés
Type de résultat : Rapports

Question

  1. What is the clinical effectiveness of intravenous (IV) ketamine for the treatment of recalcitrant Chronic Regional Pain Syndrome?
  2. What is the clinical effectiveness of IV ketamine for the treatment of Fibromyalgia?
  3. What is the clinical effectiveness of IV ketamine for the treatment of Reflex Sympathetic Dystrophy?

Messages clés

One systematic review, two randomized controlled trials, and four non-randomized studies were identified regarding the clinical effectiveness of intravenous (IV) ketamine for the treatment of chronic regional pain syndrome. No health technology assessments, systematic reviews, randomized controlled trials, or non-randomized studies were identified regarding the clinical effectiveness of IV ketamine for the treatment of fibromyalgia or reflex sympathetic dystrophy.